What is DEKA Biosciences worth?
$36.0Mlast known valuation
DEKA Biosciences last raised $29.9M in its Early Stage VC (Feb 2023).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for DEKA Biosciences
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2023 | Early Stage VC | $29.9M | ▮ | ▮ |
| Oct 2021 | Early Stage VC | $15.9M | ▮ | ▮ |
How DEKA Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For DEKA Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is DEKA Biosciences worth?
- DEKA Biosciences's last known valuation is $36.0M.
- How much has DEKA Biosciences raised?
- DEKA Biosciences has raised $104.2M in total funding across 2 recorded rounds.
- When did DEKA Biosciences last raise?
- DEKA Biosciences last raised in Feb 2023 (Early Stage VC), raising $29.9M.